Dr Katherine Ruzhansky previews presentations on biomarkers, new therapies, and translational science at AANEM 2025.

Insights from AANEM 2025, including anticipated presentations, key takeaways, and how emerging research in myasthenia gravis ...

The largest comparative review to date shows that antidepressants differ in how they affect weight, BP, and heart rate, underscoring the need for monitoring and individualized care.

Drs Joseph Mikhael and Peter Voorhees discuss considerations for treating smoldering multiple myeloma, including recent ...

New hormonal and device-based methods could soon make male contraception reliable and reversible, offering alternatives to ...

GLP-1s can cause changes in hydration, nutrition, and GI function that directly affect the mouth. Aminoshariae said these ...

HBcAb-positive, HBsAg-negative people with HIV can safely switch from tenofovir-containing ART without clinically significant ...

Results of a phase 3 study suggest that marstacimab reduces bleeding events in patients with hemophilia A and B and without ...

Researchers have developed a hydrogel that lasts longer than current treatments for vocal fold disorders and could reduce the ...

A comparative effectiveness study of glucose-lowering drugs finds the GLP-1 receptor agonists most protective against ...

Against Medical Advice’ discharge notes often include stigmatizing language, with providers expressing anger and judgment.

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...